News from ginkgo bioworks A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 01, 2021, 09:00 ET Corteva Agriscience Collaborates with Ginkgo Bioworks to Bolster Crop Protection

Corteva Agriscience LLC (NYSE: CTVA), a leading pure-play agriculture company, and Ginkgo Bioworks, Inc. ("Ginkgo") the organism company, announced...

Feb 02, 2021, 09:56 ET Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools

Today Ginkgo Bioworks, the organism company, announced that it will collaborate with the Massachusetts Department of Elementary and Secondary...

Jan 08, 2021, 13:44 ET Ginkgo Bioworks CEO to Present at the 39th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks announced today that Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 39th Annual J.P. Morgan Healthcare...

Dec 23, 2020, 10:04 ET Ginkgo Bioworks Launches COVID-19 Pooled Classroom Testing Pilot for K-12 Schools

Today Ginkgo Bioworks, the organism company, announced the launch of its pilot program to bring COVID-19 pooled testing to K-12 classrooms. The pilot ...

Dec 17, 2020, 09:00 ET Ginkgo Bioworks, Azitra, Florida International University, and Latham BioPharm Group Awarded $15M by DARPA to Develop Skin Microbiome-based Mosquito Repellent

Ginkgo Bioworks, Azitra, Inc., Florida International University (FIU), and Latham BioPharm Group (LBG) have been awarded a contract by the Defense...

Dec 16, 2020, 09:00 ET Ginkgo Bioworks Acquires Biotechnology Startup Novogy's Microbial Engineering Platform

Ginkgo Bioworks ("Ginkgo"), the organism company, today announced that it has recently completed an acquisition of the main assets of Novogy, Inc....

Dec 10, 2020, 09:00 ET Ginkgo Bioworks and Octant Partner to Expand COVID-19 Testing Capacity using Next-Generation Sequencing Technology

Today, Ginkgo Bioworks, Inc. ("Ginkgo") and Octant, Inc ("Octant") announced a partnership to grow critical diagnostic testing capacity to address...

Nov 25, 2020, 09:00 ET Ginkgo Bioworks To Expand Biosecurity and Pandemic Response Platform with $1.1B Federal Loan

Ginkgo Bioworks announced today that the U.S. International Development Finance Corporation (DFC) has approved a loan of up to $1.1 billion, enabling ...

Nov 20, 2020, 09:00 ET Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey

Today, Ginkgo Bioworks announced it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics...

Oct 26, 2020, 10:46 ET Ginkgo Bioworks Secures Access to SARS-CoV-2 Rapid Antigen Test With Goal of Acquiring and Distributing Up To 50 Million Tests

Today, Ginkgo Bioworks announced it has secured access to the SD Biosensor rapid antigen test with a goal of acquiring and distributing up to 50...

Oct 22, 2020, 09:00 ET Allonnia Launches from Ginkgo Bioworks' Ferment Consortium with $40M Series A to Address Critical Problems in Waste Remediation with Synthetic Biology, Appoints Nicole Richards as CEO

Allonnia LLC, a bioremediation company, launched today with $40 million in Series A funding to find new answers to the growing challenge of waste...

Sep 10, 2020, 09:00 ET Totient Partners with Ginkgo Bioworks to Apply Unique Discovery Platform to COVID-19 Antibody Efforts

Today, Ginkgo Bioworks announced a partnership with Totient, an AI-driven drug discovery company emerging from stealth, to rapidly identify...

Sep 10, 2020, 09:00 ET Totient Comes Out of Stealth with Novel COVID-19 Program and $10M in Seed Funding for AI-Driven Drug Discovery Platform

Today, Totient, an AI-driven drug discovery company based in Cambridge, MA, emerged from stealth with $10M in seed funding and a strategic discovery...

Jul 31, 2020, 16:06 ET Ginkgo Bioworks Awarded $40MM NIH RADx-ATP Contract to Expand High Throughput SARS-CoV-2 Testing

Today, Ginkgo Bioworks announced it has been awarded a contract from the NIH Rapid Acceleration of Diagnostics Advanced Technology Platforms...

Jun 18, 2020, 07:00 ET Ginkgo Bioworks Launches Concentric by Ginkgo to Help Enable Large-Scale COVID-19 Testing

Today, Ginkgo Bioworks announced the launch of Concentric by Ginkgo, a pandemic response program intended to create capacity for large-scale testing...

May 28, 2020, 06:00 ET Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Today, Ginkgo Bioworks is announcing a $70MM investment from Illumina (Nasdaq: ILMN) and existing Ginkgo investors, General Atlantic and Viking...

Apr 15, 2020, 09:00 ET Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response

Ginkgo Bioworks, the organism company, today announced it is contributing its platform infrastructure and expertise to a project with Moderna, Inc....

Jan 13, 2020, 10:33 ET Ginkgo Bioworks CEO to Present at the 38th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks, the organism company, today announced that Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 38th Annual J.P....

Nov 27, 2019, 09:00 ET Ginkgo Bioworks Joins the Ellen MacArthur Foundation's Circular Economy 100 (CE100) Network

Ginkgo Bioworks, the organism company, today announced it has joined the Ellen MacArthur Foundation's Circular Economy 100 (CE100) Network, the...

Oct 10, 2019, 09:00 ET Ginkgo Bioworks Announces the Ferment Consortium, a $350 Million Investment Vehicle to Disrupt Established Markets with New Synthetic Biology Companies

Today at Ginkgo Bioworks' second annual Ferment meeting, the organism company unveiled the Ferment Consortium, a private investment vehicle for...

Oct 01, 2019, 09:00 ET Ginkgo Bioworks and Berkeley Lights Bring Unprecedented Speed and Scale to Synthetic Biology with $150MM Collaboration

Ginkgo Bioworks, the organism company and Berkeley Lights, Inc., a company dedicated to finding the best cells, today announced a $150MM...

Sep 19, 2019, 06:00 ET Ginkgo Bioworks Raises $290 Million in Series E Financing to Grow its Platform for Cell Programming

Today, Ginkgo Bioworks, the organism company, announced a Series E financing round of $290 million with participation from all existing major...

May 15, 2019, 06:00 ET Ginkgo Bioworks Acquires Warp Drive Bio's Genome Mining Platform for Discovery and Development of Novel Classes of Antibiotics

Ginkgo Bioworks, the organism company, today announced it acquired the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION...

May 08, 2019, 09:00 ET At the Intersection of Art and Science: The smell of extinct flowers resurrected with synthetic biology in new exhibit opening at Nature--Cooper Hewitt Design Triennial

Is it possible to resurrect the scent of long-lost flowers, driven to extinction by humans over a century ago? Now, thanks to a one-of-a-kind...

Apr 16, 2019, 06:00 ET Ginkgo Bioworks Appoints Former Bayer CEO Marijn Dekkers as Chairman of its Board of Directors

Ginkgo Bioworks, the organism company, today announced the appointment of Dr. Marijn Dekkers, former CEO of Bayer AG and of Thermo Fisher Scientific...